OpenURL Connection Search

Select item for more details and to access through your institution.

Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.
Published in:
Patient Preference & Adherence, 2022, v. 16, p. 573, doi. 10.2147/PPA.S345906
By:
- Auclair, Daniel;
- Mansfield, Carol;
- Fiala, Mark A;
- Chari, Ajai;
- Cole, Craig E;
- Kaufman, Jonathan L;
- Orloff, Gregory J;
- Siegel, David S;
- Zonder, Jeffrey A;
- Mange, Brennan;
- Yesil, Jennifer;
- Dalal, Mehul;
- Mikhael, Joseph R
Publication type:
Article
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Published in:
British Journal of Haematology, 2019, v. 186, n. 4, p. 549, doi. 10.1111/bjh.15969
By:
- Jakubowiak, Andrzej J.;
- Jasielec, Jagoda K.;
- Rosenbaum, Cara A.;
- Cole, Craig E.;
- Chari, Ajai;
- Mikhael, Joseph;
- Nam, Jennifer;
- McIver, Amanda;
- Severson, Erica;
- Stephens, Leonor A.;
- Tinari, Kathryn;
- Rosebeck, Shaun;
- Zimmerman, Todd M.;
- Hycner, Tyler;
- Turowski, Agata;
- Karrison, Theodore;
- Zonder, Jeffrey A.
Publication type:
Article
Daratumumab proves safe and highly effective in AL amyloidosis.
Published in:
British Journal of Haematology, 2019, v. 185, n. 2, p. 342, doi. 10.1111/bjh.15455
By:
- Khouri, Jack;
- Kin, Andrew;
- Thapa, Bicky;
- Reu, Frederic J.;
- Bumma, Naresh;
- Samaras, Christy J.;
- Liu, Hien D.;
- Karam, Mary A.;
- Reed, Janice;
- Mathur, Saveta;
- Faiman, Beth M.;
- Devries, Georgia;
- Zonder, Jeffrey;
- Valent, Jason
Publication type:
Article
The difficult business of assessing new therapies for smouldering multiple myeloma.
Published in:
2018
By:
- Zonder, Jeffrey A.
Publication type:
Editorial
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma ( NPI-0052-107): final study results.
Published in:
British Journal of Haematology, 2018, v. 180, n. 1, p. 41, doi. 10.1111/bjh.14987
By:
- Spencer, Andrew;
- Harrison, Simon;
- Zonder, Jeffrey;
- Badros, Ashraf;
- Laubach, Jacob;
- Bergin, Krystal;
- Khot, Amit;
- Zimmerman, Todd;
- Chauhan, Dharminder;
- Levin, Nancy;
- MacLaren, Ann;
- Reich, Steven D.;
- Trikha, Mohit;
- Richardson, Paul
Publication type:
Article
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
Published in:
Annals of Hematology, 2021, v. 100, n. 9, p. 2325, doi. 10.1007/s00277-021-04534-8
By:
- Davies, Faith;
- Rifkin, Robert;
- Costello, Caitlin;
- Morgan, Gareth;
- Usmani, Saad;
- Abonour, Rafat;
- Palumbo, Antonio;
- Romanus, Dorothy;
- Hajek, Roman;
- Terpos, Evangelos;
- Cherepanov, Dasha;
- Stull, Dawn Marie;
- Huang, Hui;
- Leleu, Xavier;
- Berdeja, Jesus;
- Lee, Hans C.;
- Weisel, Katja;
- Thompson, Michael;
- Boccadoro, Mario;
- Zonder, Jeffrey
Publication type:
Article
Circular RNAs in acute myeloid leukemia.
Published in:
Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01446-z
By:
- Singh, Vijendra;
- Uddin, Mohammed Hafiz;
- Zonder, Jeffrey A.;
- Azmi, Asfar S.;
- Balasubramanian, Suresh Kumar
Publication type:
Article
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma.
Published in:
Cancers, 2022, v. 14, n. 1, p. 160, doi. 10.3390/cancers14010160
By:
- Khan, Husain Yar;
- Uddin, Md. Hafiz;
- Balasubramanian, Suresh Kumar;
- Sulaiman, Noor;
- Iqbal, Marium;
- Chaker, Mahmoud;
- Aboukameel, Amro;
- Li, Yiwei;
- Senapedis, William;
- Baloglu, Erkan;
- Mohammad, Ramzi M.;
- Zonder, Jeffrey;
- Azmi, Asfar S.
Publication type:
Article
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
Published in:
European Journal of Haematology, 2023, v. 110, n. 5, p. 564, doi. 10.1111/ejh.13937
By:
- Derman, Benjamin A;
- Chari, Ajai;
- Zonder, Jeffrey;
- Major, Ajay;
- Stefka, Andrew T;
- Jiang, Ken;
- Karrison, Theodore;
- Jasielec, Jagoda;
- Jakubowiak, Andrzej
Publication type:
Article
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
Published in:
Cancer Medicine, 2022, v. 11, n. 2, p. 358, doi. 10.1002/cam4.4451
By:
- Pan, Darren;
- Kaufman, Jonathan L.;
- Htut, Myo;
- Agrawal, Manish;
- Mazumder, Amitabha;
- Cornell, Robert F.;
- Zonder, Jeffrey A.;
- Fay, Joseph W.;
- Modiano, Manuel R.;
- Moshier, Erin L.;
- Rush, Selena A.;
- Tunquist, Brian J.;
- Chari, Ajai
Publication type:
Article
A phase II trial of BAY 43-9006 (sorafenib) ( NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.
Published in:
Cancer Medicine, 2014, v. 3, n. 5, p. 1275, doi. 10.1002/cam4.276
By:
- Srkalovic, Gordan;
- Hussein, Mohamad A.;
- Hoering, Antje;
- Zonder, Jeffrey A.;
- Popplewell, Leslie L.;
- Trivedi, Harsha;
- Mazzoni, Sandy;
- Sexton, Rachel;
- Orlowski, Robert Z.;
- Barlogie, Bart
Publication type:
Article
Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer.
Published in:
2006
By:
- Bennett, Charles L.;
- Angelotta, Cara;
- Yarnold, Paul R.;
- Evens, Andrew M.;
- Zonder, Jeffrey A.;
- Raisch, Dennis W.;
- Richardson, Paul
Publication type:
Letter
Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited.
Published in:
Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/801495
By:
- Jay Yang;
- Terebelo, Howard R.;
- Zonder, Jeffrey A.
Publication type:
Article
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.
Published in:
Supportive Care in Cancer, 2013, v. 21, n. 9, p. 2437, doi. 10.1007/s00520-013-1808-5
By:
- Bhutani, Divaya;
- Zonder, Jeffrey;
- Valent, Jason;
- Tageja, Nishant;
- Ayash, Lois;
- Deol, Abhinav;
- Al-Kadhimi, Zaid;
- Abrams, Judith;
- Lum, Lawrence;
- Ratanatharathorn, Voravit;
- Uberti, Joseph;
- Abidi, Muneer
Publication type:
Article
Precursor T Cell Acute Lymphoblastic Lymphoma Presenting as Bilateral Facial Nerve Palsy.
Published in:
Chemotherapy (0009-3157), 2010, v. 56, n. 3, p. 258, doi. 10.1159/000316847
By:
- Tageja, Nishant;
- Valent, Jason;
- Bentley, Gail;
- Zonder, Jeffrey
Publication type:
Article
Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma.
Published in:
Blood & Lymphatic Cancer: Targets & Therapy, 2017, p. 53, doi. 10.2147/BLCTT.S82444
By:
- Bhutani, Divaya;
- Zonder, Jeffrey A.
Publication type:
Article
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
By:
- Thompson, Michael A.;
- Boccadoro, Mario;
- Leleu, Xavier;
- Vela-Ojeda, Jorge;
- Rhee, Frits van;
- Weisel, Katja C.;
- Rifkin, Robert M.;
- Usmani, Saad Z.;
- Hájek, Roman;
- Cook, Gordon;
- Abonour, Rafat;
- Armour, Mira;
- Morgan, Kathryn E.;
- Yeh, Su-Peng;
- Costello, Caitlin L.;
- Berdeja, Jesus G.;
- Davies, Faith E.;
- Zonder, Jeffrey A.;
- Lee, Hans C.;
- Omel, Jim
Publication type:
Article
P-225: A first-in-human study of FOR46 in patients with triple refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S164, doi. 10.1016/S2152-2650(21)02352-1
By:
- Wong, Sandy;
- Imus, Philip;
- Mark, Tomer;
- Kaufman, Jonathan;
- Imus, Ajai;
- Zonder, Jeffrey A.;
- Walker, Zachary;
- Sherbenou, Daniel;
- Schroeder, Mark;
- Abbey, Jill;
- Nasoff, Marc;
- Dorr, Andrew;
- Liu, Bin;
- Martin, Thomas
Publication type:
Article
P-064: Heterogeneity of bone marrow biopsy and bone marrow aspirate (BMA) in patients with heavily pretreated relapsed/refractory Multiple Myeloma (RRMM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S73, doi. 10.1016/S2152-2650(21)02198-4
By:
- Boyapati, Anita;
- Fiaschi, Nathalie;
- Dhodapkar, Madhav V.;
- Jagannath, Sundar;
- Zonder, Jeffrey A.;
- Wang, Fang;
- Coetzee, Sandra;
- Noguera-Troise, Irene;
- Lorenc, Karen Rodriguez;
- Kroog, Glenn;
- Sharma, Manish
Publication type:
Article
A Randomized Phase 2 Study of Subcutaneous Daratumumab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone Alone in Patients with Multiple Myeloma who have been Previously Treated with Intravenous Daratumumab to Evaluate Retreatment (LYNX).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e246, doi. 10.1016/j.clml.2019.09.408
By:
- Bahlis, Nizar J.;
- Zonder, Jeffrey A.;
- Wroblewski, Susan;
- Qi, Ming;
- Renaud, Thomas;
- Jackson, Carolyn;
- Facon, Thierry
Publication type:
Article
A Phase 1b/2a Study of the CELMoD Iberdomide (CC-220) in Combination With Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e52, doi. 10.1016/j.clml.2019.09.080
By:
- Lonial, Sagar;
- Van de Donk, Niels;
- Popat, Rakesh;
- Zonder, Jeffrey A.;
- Minnema, Monique;
- Larsen, Jeremy T.;
- Nguyen, Tuong Vi;
- Chen, Min S.;
- Bensmaine, Amine;
- Peluso, Teresa;
- Sonneveld, Pieter
Publication type:
Article
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e4, doi. 10.1016/j.clml.2019.09.006
By:
- Weisel, Katja;
- Hungria, Vania;
- Leleu, Xavier;
- Lee, Hans;
- Rifkin, Robert;
- Costello, Caitlin;
- Abonour, Rafat;
- Chari, Ajai;
- Puig, Noemi;
- Berdeja, Jesus;
- Cook, Gordon;
- Thompson, Michael A.;
- Boccadoro, Mario;
- Terpos, Evangelos;
- Zonder, Jeffrey A.;
- Vela-Ojeda, Jorge;
- Davies, Faith;
- van Rhee, Frits;
- Hajek, Roman;
- Spencer, Andrew
Publication type:
Article
HORIZON (OP-106) Study of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S329, doi. 10.1016/j.clml.2019.07.318
By:
- Richardson, Paul G.;
- Oriol, Albert;
- Larocca, Alessandra;
- Otero, Paula Rodriguez;
- Norkin, Maxim;
- Bladé, Joan;
- Cavo, Michele;
- Hassoun, Hani;
- Leleu, Xavier;
- Alegre, Adrián;
- Maisel, Christopher;
- Paner, Agne;
- Mazumder, Amitabha;
- Zonder, Jeffrey A.;
- Puig, Noemí;
- Harran, John;
- Harmenberg, Johan;
- Thuresson, Sara;
- Zubair, Hanan;
- Mateos, Maria-Victoria
Publication type:
Article
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146
By:
- Costello, Caitlin;
- Boccadoro, Mario;
- Usmani, Saad Z.;
- Chari, Ajai;
- Rifkin, Robert M.;
- Abonour, Rafat;
- Berdeja, Jesus;
- Cook, Gordon;
- Goldschmidt, Hartmut;
- Hajek, Roman;
- Hungria, Vania;
- Lee, Hans C.;
- Leleu, Xavier;
- Omel, Jim;
- Spencer, Andrew;
- Thompson, Michael A.;
- Vela-Ojeda, Jorge;
- Zonder, Jeffrey A.;
- Puig, Noemi;
- Aguarón, Alfonso
Publication type:
Article
Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Response.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e97, doi. 10.1016/j.clml.2017.03.175
By:
- Gertz, Morie A.;
- Comenzo, Raymond L.;
- Landau, Heather;
- Sanchorawala, Vaishali;
- Weiss, Brendan M.;
- Zonder, Jeffrey A.;
- Walling, Jackie;
- Kinney, Gene G.;
- Koller, Martin;
- Schenk, Dale B.;
- Guthrie, Spencer D.;
- Liu, Enchi;
- Liedtke, Michaela
Publication type:
Article
NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From a Phase 1/2 Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e22, doi. 10.1016/j.clml.2017.03.038
By:
- Gertz, Morie A.;
- Comenzo, Raymond L.;
- Landau, Heather;
- Sanchorawala, Vaishali;
- Weiss, Brendan M.;
- Zonder, Jeffrey A.;
- Walling, Jackie;
- Kinney, Gene G.;
- Koller, Martin;
- Schenk, Dale B.;
- Guthrie, Spencer D.;
- Liu, Enchi;
- Liedtke, Michaela
Publication type:
Article
Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e79, doi. 10.1016/j.clml.2017.03.144
By:
- Rifkin, Robert;
- Davies, Faith;
- Palumbo, Antonio;
- Zonder, Jeffrey A.;
- Girnius, Saulius;
- Costello, Caitlin;
- Usmani, Saad;
- Berdeja, Jesus;
- Omel, Jim;
- Thompson, Michael;
- Schwartz, J Sanford;
- Hajek, Roman;
- Terpos, Evangelos;
- Hungria, Vania;
- Mateos, Maria-Victoria;
- Cook, Gordon;
- Leleu, Xavier;
- Spencer, Andrew;
- Goldschmidt, Hartmut;
- Seal, Brian
Publication type:
Article
Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study.
Published in:
2016
By:
- Berdeja, Jesus;
- Jagannath, Sundar;
- Zonder, Jeffrey;
- Badros, Ashraf;
- Kaufman, Jonathan L.;
- Manges, Robert;
- Gupta, Manish;
- Tendolkar, Amol;
- Lynch, Mark;
- Bleickardt, Eric;
- Paliwal, Prashni;
- Vij, Ravi
Publication type:
journal article
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.
Published in:
2021
By:
- Mikhael, Joseph;
- Belhadj-Merzoug, Karim;
- Hulin, Cyrille;
- Vincent, Laure;
- Moreau, Philippe;
- Gasparetto, Cristina;
- Pour, Ludek;
- Spicka, Ivan;
- Vij, Ravi;
- Zonder, Jeffrey;
- Atanackovic, Djordje;
- Gabrail, Nashat;
- Martin, Thomas G.;
- Perrot, Aurore;
- Bensfia, Samira;
- Weng, Qilong;
- Brillac, Claire;
- Semiond, Dorothée;
- Macé, Sandrine;
- Corzo, Kathryn P.
Publication type:
Letter to the Editor
Chronic lymphocytic leukemia presenting in association with aplastic anemia.
Published in:
American Journal of Hematology, 2002, v. 71, n. 4, p. 323, doi. 10.1002/ajh.10226
By:
- Zonder, Jeffrey A.;
- Keating, Michael;
- Schiffer, Charles A.
Publication type:
Article
A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed/refractory multiple myeloma.
Published in:
2017
By:
- Shah, Jatin J.;
- Kaufman, Jonathan L.;
- Zonder, Jeffrey A.;
- Cohen, Adam D.;
- Bensinger, William I.;
- Hilder, Brandi W.;
- Rush, Selena A.;
- Walker, Duncan H.;
- Tunquist, Brian J.;
- Litwiler, Kevin S.;
- Ptaszynski, Mieke;
- Orlowski, Robert Z.;
- Lonial, Sagar
Publication type:
journal article
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.
Published in:
2016
By:
- Chari, Ajai;
- Htut, Myo;
- Zonder, Jeffrey A.;
- Fay, Joseph W.;
- Jakubowiak, Andrzej J.;
- Levy, Joan B.;
- Lau, Kenneth;
- Burt, Steven M.;
- Tunquist, Brian J.;
- Hilder, Brandi W.;
- Rush, Selena A.;
- Walker, Duncan H.;
- Ptaszynski, Mieke;
- Kaufman, Jonathan L.
Publication type:
journal article
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function.
Published in:
Cancer (0008543X), 2010, v. 116, n. 16, p. 3807, doi. 10.1002/cncr.25139
By:
- Dimopoulos, Meletios;
- Alegre, Adrian;
- Stadtmauer, Edward A.;
- Goldschmidt, Hartmut;
- Zonder, Jeffrey A.;
- de Castro, Carlos M.;
- Masliak, Zvenyslava;
- Reece, Donna;
- Olesnyckyj, Marta;
- Yu, Zhinuan;
- Weber, Donna M.
Publication type:
Article
Myonecrosis in Sickle Cell Anemia--Overlooked and Underdiagnosed.
Published in:
2010
By:
- Tageja, Nishant;
- Racovan, Marius;
- Valent, Jason;
- Zonder, Jeffrey
Publication type:
Case Study
Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma.
Published in:
Oncology & Therapy, 2016, v. 4, n. 2, p. 287, doi. 10.1007/s40487-016-0034-y
By:
- Baz, Rachid;
- Zonder, Jeffrey;
- Gasparetto, Cristina;
- Reu, Frederic;
- Strout, Vincent
Publication type:
Article
Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.
Published in:
Current Hematologic Malignancy Reports, 2006, v. 1, n. 3, p. 141, doi. 10.1007/s11899-996-0002-y
By:
- Zonder, Jeffrey;
- Schiffer, Charles
Publication type:
Article

Found: 36